pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 22·1 min read
save

Hospital AI oversight lagging; senior leaders must take daily responsibility

Jul 22, 2026·read at STAT ↗Neutral

AI tools are now common in U.S. hospitals, handling tasks such as drafting clinical notes, flagging sepsis, screening imaging, processing prior authorizations, and responding to patient messages.

While the benefits are evident, most health systems still monitor these tools with the same slow, checklist-driven process used for older equipment like MRI scanners, often requiring quarterly meetings and six-month approvals.

The authors argue that this model is unsafe for AI and that fixing problems should not be left to IT departments alone; senior leadership must assume direct responsibility for AI oversight.

They call for daily AI governance to become a routine part of executive duties, ensuring that safety and performance are continuously monitored rather than reviewed only intermittently.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?”

read at STAT ↗
432 words · retrieved Jul 22
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Bio TTestimVogelxotestosterone
topics
Approval

related stories

  • Jul 22Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changerSTAT
  • Jul 24A new, separate outbreak of the diarrhea-causing parasiteSTAT
  • Jul 23Expect a clash at today’s FDA peptide panelSTAT
  • Jul 23Opinion: New billing codes likely to raise maternity care costsSTAT
  • Jul 23Opinion: Good riddance to bundled ‘global’ maternal care billingSTAT